Northcape Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $241K | Hold |
3,450
| – | – | 0.07% | 128 |
|
|
2025
Q1 | $254K | Hold |
3,450
| – | – | 0.08% | 124 |
|
|
2024
Q4 | $226K | Hold |
3,450
| – | – | 0.07% | 128 |
|
|
2024
Q3 | $269K | Hold |
3,450
| – | – | 0.09% | 122 |
|
|
2024
Q2 | $269K | Buy |
+3,450
| New | +$269K | 0.1% | 121 |
|
|
2024
Q1 | – | Sell |
-3,450
| Closed | -$232K | – | 134 |
|
|
2023
Q4 | $232K | Hold |
3,450
| – | – | 0.08% | 125 |
|
|
2023
Q3 | $234K | Hold |
3,450
| – | – | 0.09% | 131 |
|
|
2023
Q2 | $247K | Hold |
3,450
| – | – | 0.09% | 139 |
|
|
2023
Q1 | $239K | Buy |
+3,450
| New | +$239K | 0.09% | 135 |
|
|
2022
Q3 | – | Sell |
-3,450
| Closed | -$228K | – | 137 |
|
|
2022
Q2 | $228K | Sell |
3,450
-50
| -1% | -$3.3K | 0.09% | 112 |
|
|
2022
Q1 | $232K | Sell |
3,500
-500
| -13% | -$33.1K | 0.07% | 140 |
|
|
2021
Q4 | $233K | Buy |
+4,000
| New | +$233K | 0.08% | 119 |
|